140 related articles for article (PubMed ID: 24419752)
1. Myopathy in scleroderma, its identification, prevalence, and treatment: lessons learned from cohort studies.
Paik JJ; Mammen AL; Wigley FM; Gelber AC
Curr Opin Rheumatol; 2014 Mar; 26(2):124-30. PubMed ID: 24419752
[TBL] [Abstract][Full Text] [Related]
2. Skin lesions in anti-Pm-Scl-70 positive systemic sclerosis-dermatomyositis overlap syndrome improve during local PUVA phototherapy.
Mohanna M; Distler O; Sprott H; Kündig T; French LE; Hofbauer G
Eur J Dermatol; 2013; 23(5):730-1. PubMed ID: 24126033
[No Abstract] [Full Text] [Related]
3. Myopathy in scleroderma and in other connective tissue diseases.
Paik JJ
Curr Opin Rheumatol; 2016 Nov; 28(6):631-5. PubMed ID: 27548651
[TBL] [Abstract][Full Text] [Related]
4. Muscle disease in scleroderma.
Paik JJ
Curr Opin Rheumatol; 2018 Nov; 30(6):576-580. PubMed ID: 30148800
[TBL] [Abstract][Full Text] [Related]
5. [Muscle involvement in Systemic Sclerosis - diagnosis evaluation].
Pinto L; Castelão W; Branco JC
Acta Reumatol Port; 2010; 35(2):142-5. PubMed ID: 20711089
[TBL] [Abstract][Full Text] [Related]
6. The human exosome: an autoantigenic complex of exoribonucleases in myositis and scleroderma.
Brouwer R; Pruijn GJ; van Venrooij WJ
Arthritis Res; 2001; 3(2):102-6. PubMed ID: 11178117
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of autoantibodies in dermatomyositis and systemic sclerosis.
Tartar DM; Chung L; Fiorentino DF
Clin Dermatol; 2018; 36(4):508-524. PubMed ID: 30047434
[TBL] [Abstract][Full Text] [Related]
8. [Systemic sclerosis autoantibodies: what dermatologists must know].
Hüe S; Ingen-Housz-Oro S; Cosnes A
Ann Dermatol Venereol; 2013 Feb; 140(2):143-9. PubMed ID: 23395500
[No Abstract] [Full Text] [Related]
9. Reply: To PMID 24577935.
D'Aoust J; Hudson M; Baron M; Mahler M; Fritzler MJ
Arthritis Rheumatol; 2014 Nov; 66(11):3249-50. PubMed ID: 25077459
[No Abstract] [Full Text] [Related]
10. Scleroderma/polymyositis overlap syndromes and their immunologic markers.
Jablonska S; Chorzelski TP; Blaszczyk M; Jarzabek-Chorzelska M; Kumar V; Beutner EH
Clin Dermatol; 1992; 10(4):457-72. PubMed ID: 1303810
[No Abstract] [Full Text] [Related]
11. Spectrum of Muscle Histopathologic Findings in Forty-Two Scleroderma Patients With Weakness.
Paik JJ; Wigley FM; Lloyd TE; Corse AM; Casciola-Rosen L; Shah AA; Boin F; Hummers LK; Mammen AL
Arthritis Care Res (Hoboken); 2015 Oct; 67(10):1416-25. PubMed ID: 25989455
[TBL] [Abstract][Full Text] [Related]
12. Myopathies related to systemic sclerosis: a case-control study of associated clinical and immunological features.
Ranque B; Bérezné A; Le-Guern V; Pagnoux C; Allanore Y; Launay D; Hachulla E; Authier FJ; Gherardi R; Kahan A; Cabane J; Guillevin L; Mouthon L
Scand J Rheumatol; 2010 Nov; 39(6):498-505. PubMed ID: 20726682
[TBL] [Abstract][Full Text] [Related]
13. Myopathy is a poor prognostic feature in systemic sclerosis: results from the Canadian Scleroderma Research Group (CSRG) cohort.
Jung M; Bonner A; Hudson M; Baron M; Pope JE;
Scand J Rheumatol; 2014; 43(3):217-20. PubMed ID: 24650305
[TBL] [Abstract][Full Text] [Related]
14. Is the measurement of anti-PM-1α antibodies at least as important as that of other systemic sclerosis-specific antibodies? Comment on the article by D'Aoust et al.
Muro Y; Sugiura K; Akiyama M
Arthritis Rheumatol; 2014 Nov; 66(11):3248. PubMed ID: 25077816
[No Abstract] [Full Text] [Related]
15. Anti-Ku Antibody-Related Scleroderma-Polymyositis Overlap Syndrome Associated With Hypothyroid Myopathy.
Kadowaki Y; Horino T; Kashio T; Nishikawa H; Inotani S; Matsumoto T; Ishihara M; Ichii O
J Clin Rheumatol; 2021 Aug; 27(5):e200-e201. PubMed ID: 32345845
[No Abstract] [Full Text] [Related]
16. Muscle disease in progressive systemic sclerosis: diagnostic and therapeutic considerations.
Clements PJ; Furst DE; Campion DS; Bohan A; Harris R; Levy J; Paulus HE
Arthritis Rheum; 1978; 21(1):62-71. PubMed ID: 623695
[TBL] [Abstract][Full Text] [Related]
17. Scleromyositis: a scleroderma/polymyositis overlap syndrome.
Jablonska S; Blaszczyk M
Clin Rheumatol; 1998; 17(6):465-7. PubMed ID: 9890673
[No Abstract] [Full Text] [Related]
18. C1D is a major autoantibody target in patients with the polymyositis-scleroderma overlap syndrome.
Schilders G; Egberts WV; Raijmakers R; Pruijn GJ
Arthritis Rheum; 2007 Jul; 56(7):2449-54. PubMed ID: 17599775
[TBL] [Abstract][Full Text] [Related]
19. The human exosome and disease.
Staals RH; Pruijn GJ
Adv Exp Med Biol; 2011; 702():132-42. PubMed ID: 21713683
[TBL] [Abstract][Full Text] [Related]
20. Systemic sclerosis associated myopathy.
Chaigne B; Léonard-Louis S; Mouthon L
Autoimmun Rev; 2023 Feb; 22(2):103261. PubMed ID: 36549354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
